Stockscreener 앱 받기
3.17
1.93%
0.06
전일 마감가:
$3.11
열려 있는:
$3.1
하루 거래량:
256.77K
Relative Volume:
0.34
시가총액:
$250.83M
수익:
$130.42M
순이익/손실:
$18.64M
주가수익비율:
14.53
EPS:
0.2182
순현금흐름:
$4.05M
1주 성능:
-3.65%
1개월 성능:
-8.65%
6개월 성능:
-35.83%
1년 성능:
-65.99%
1일 변동 폭
$3.07
$3.17
1주일 범위
$3.07
$3.275
52주 변동 폭
$2.87
$10.52
Niagen Bioscience Inc Stock (NAGE) Company Profile
명칭
Niagen Bioscience Inc
전화
310-388-6706
주소
10900 WILSHIRE BLVD, LOS ANGELES
Compare NAGE vs VRTX, REGN, ARGX, MRNA, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NAGE
Niagen Bioscience Inc
|
3.17 | 249.25M | 130.42M | 18.64M | 4.05M | 0.2182 |
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Niagen Bioscience Inc Stock (NAGE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-27 | 개시 | Canaccord Genuity | Buy |
| 2022-08-16 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2022-08-11 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2022-03-08 | 개시 | ROTH Capital | Buy |
| 2019-10-16 | 개시 | Oppenheimer | Outperform |
| 2019-02-14 | 개시 | B. Riley FBR | Buy |
| 2017-11-27 | 재개 | H.C. Wainwright | Buy |
| 2017-09-25 | 개시 | Ladenburg Thalmann | Buy |
| 2017-01-03 | 개시 | Rodman & Renshaw | Buy |
모두보기
Niagen Bioscience Inc 주식(NAGE)의 최신 뉴스
Niagen Bioscience Leads The Way With 2 Promising Penny Stocks - simplywall.st
Supplement Retail Expansions - Trend Hunter
Niagen Bioscience expands Tru Niagen to GNC, Sam’s Club stores - Investing.com
Niagen Bioscience expands Tru Niagen to GNC, Sam’s Club stores By Investing.com - Investing.com India
Niagen Bioscience Expands Tru Niagen® Retail Footprint with GNC and Sam’s Club - New Castle News
Tieton Capital Management LLC Purchases New Position in Niagen Bioscience, Inc. $NAGE - MarketBeat
Niagen (NAGE) Results at a Glance: EPS Does Not Reach the Reported Estimate for the Current Session; Price Reaction: The Stock Gains 4.71%Earnings Stability Report - vinanet.vn
Niagen (NAGE): Closes 0.33% Higher at $3.05 on the Day; Range and Risk: the Supplied Trading Band Runs From $2.90 to $3.20 on the DayAndrews Pitchfork - vinanet.vn
Niagen Bioscience (NAGE) Eases to $3.02 as Support Level Comes into FocusLong Term Entry Picks - Vinanet
Niagen Bioscience, Inc. (NASDAQ: NAGE) Share Price, NAGE Stock News, NAGE Share Price & Updates - Kalkine
Niagen Bioscience (NAGE) Holds Above $2.9 Support as Shares Drift LowerArms Index - vinanet.vn
Niagen Bioscience to Present at Midwest IDEAS Investor Conference - Bitget
Niagen Bioscience at canaccord growth conference: cash, science and growth By Investing.com - Investing.com India
Niagen Bioscience at canaccord growth conference: cash, science and growth - Investing.com
Niagen Bioscience (NAGE) Gains Fresh Momentum, Is The Stock Still Cheap? - simplywall.st
HC Wainwright Forecasts Lower Earnings for Niagen Bioscience - MarketBeat
Niagen Bioscience, Inc. (NAGE) Stock Analysis: A 297% Upside Potential Awaits Investor Attention - DirectorsTalk Interviews
Is Niagen Bioscience (NAGE) Quietly Recasting Its Brand Around E‑Commerce Scale And Clinical Proof - simplywall.st
Niagen Bioscience launches Tru Niagen on Walmart.com - Investing.com India
HC Wainwright Predicts Weaker Earnings for Niagen Bioscience - MarketBeat
Niagen Bioscience Launches Tru Niagen on Walmart.com, Expanding Access and Diversifying Its E-commerce Marketplace Presence - Yahoo Finance
NAGE Stock Price and Chart — NASDAQ:NAGE - TradingView
Sei Investments Co. Increases Holdings in Niagen Bioscience, Inc. $NAGE - marketbeat.com
Niagen Bioscience, Inc. $NAGE Holdings Boosted by Renaissance Technologies LLC - MarketBeat
Niagen Bioscience (NAGE) On New Aging Study And The Case For A Higher Fair Value - Yahoo Finance
Niagen Bioscience (NAGE) Stock Sinks As Profit Cushion Thins - simplywall.st
Q2 2026 Niagen Bioscience Inc Earnings Call Transcript - GuruFocus
CCORF Maintains Niagen Bioscience(NAGE.US) With Buy Rating, Maintains Target Price $10 - Moomoo
Niagen Bioscience, Inc. (NASDAQ:NAGE) Given Consensus Rating of "Buy" by Brokerages - MarketBeat
Niagen Bioscience Inc (NAGE) (Q2 2026) Earnings Call Highlights: - GuruFocus
Niagen Bioscience, Inc. Stock 12‑Month Price Target Cut to $12.08, Implies 248% Upside - TradingView
Earnings call transcript: Niagen Bioscience posts q2 2026 growth, lifts spending - Investing.com Canada
Niagen Bioscience (NASDAQ:NAGE) Announces Quarterly Earnings Results, Meets Expectations - MarketBeat
Is Niagen Bioscience Inc (NAGE) Undervalued After Q2 Earnings Mi - GuruFocus
Niagen Bioscience (NAGE) Meets Q2 Earnings Estimates - Yahoo Finance
Niagen Bioscience, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:NAGE) 2026-08-04 - Seeking Alpha
Niagen Bioscience Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Niagen Bioscience: Q2 Earnings Snapshot - Barchart.com
Niagen Bioscience, Inc. (NAGE) Q2 FY2026 earnings call transcript - Yahoo Finance
Niagen Bioscience 2026: Revenue $29.79M, EPS $0.01— 10-Q Summary - TradingView
Press Release: Niagen Bioscience, Inc. Reports Second Quarter 2026 Financial Results - 富途牛牛
[10-Q] Niagen Bioscience, Inc. Quarterly Earnings Report - Stock Titan
Niagen Bioscience, Inc. Reports Second Quarter 2026 Financial Results - Yahoo Finance
Niagen Bioscience selects Evotec for rare disease drug studies - Investing.com
Niagen Bioscience selects Evotec for rare disease drug studies By Investing.com - Investing.com Nigeria
Arrowstreet Capital Limited Partnership Buys 761,685 Shares of Niagen Bioscience, Inc. $NAGE - MarketBeat
Niagen Bioscience, Inc. (OCD1) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
Niagen Bioscience, Inc. (NAGE): Investor Outlook Highlights Potential 274% Upside - DirectorsTalk Interviews
Niagen Bioscience Inc expected to post earnings of 2 cents a shareEarnings Preview - TradingView
Niagen Bioscience, Inc. Revenue Breakdown – DUS:OCD1 - TradingView
Niagen Bioscience reports study on muscle aging markers By Investing.com - Investing.com Canada
Niagen Bioscience Inc (NAGE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Niagen Bioscience Inc 주식 (NAGE) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Pamir Ozan | Chief Financial Officer |
Nov 14 '25 |
Buy |
6.81 |
4,465 |
30,406 |
7,372 |
| Pamir Ozan | Chief Financial Officer |
Nov 14 '25 |
Buy |
6.85 |
2,220 |
15,210 |
2,220 |
0.86%
0.31%
자본화:
|
볼륨(24시간):